Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD
Status:
Withdrawn
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the effect of increasing nasal teriparatide dosing
on percent change in Bone Mineral Density (BMD) of the lumbar spine after 24 weeks of therapy
in postmenopausal women with low bone mineral density.